Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system
US6168932A · kind A · utility
84Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 1998 |
| Grant date | Jan 2, 2001 |
| Priority date | — |
| Expiry date | Jul 13, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A soluble form of DT.sub.ct GMCSF is produced with high yield in insect cells, preferably using the baculovirus expression vector system (BEVS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.